J. Michael Ryan, MD
Assistant Professor of Psychiatry
University of Rochester Medical Center
Lori Daiello, PharmD, BCPP
Geriatric Psychopharmacology Specialist
President, Pharmacotherapy Solutions
Joseph P. Moore, MS
Director of Nursing
Monroe Community Hospital
Physician CME & Pharmacy CE: 1.0
Nurse/NP CE: 1.2 Medium
CREDIT FOR THIS PROGRAM IS AVAILABLE FOR PHYSICIANS, PHARMACISTS, NURSES, AND NURSE PRACTITIONERS. PHYSICIAN ASSISTANTS QUALIFY FOR CME CREDIT--SEE CREDIT STATEMENTS, BELOW.
Agitation and psychosis are highly prevalent among elderly patients who have been diagnosed with Alzheimer’s disease or other dementias. If severe and persistent, these symptoms can endanger the patient and others and compromise health outcomes and quality of life. A wide range of medications is commonly employed to treat these symptoms, including atypical and conventional antipsychotics, antidepressants, anxiolytics, and anticonvulsants. However, it is also critical that nonpharmacologic interventions be incorporated into the treatment plan. In the long-term care environment, nonpharmacologic interventions are an important part of regulatory considerations, especially when treating dementia-related behavioral symptoms. This audioconference will use a multidisciplinary perspective to address the spectrum of options available to clinicians caring for elderly long-term care residents with psychosocial disorders. Program Developer/Facilitator
. Target Audience
Physicians, pharmacists, nurses, and nurse practitioners involved in caring for geriatric patients.
Upon completion of this educational activity, the participant should be able to:
Describe how a multidisciplinary team approach involving physicians, pharmacists, nurses and other healthcare professionals can optimize the mental health outcomes of patients in the long-term care setting.
Explore the ramifications of treating long-term care patients in the context of the current medico-legal and regulatory environment.
Differentiate between agitation, psychosis, and other types of dementia-related behavioral symptoms commonly observed in elderly patients.
Identify which types of patients are most likely to benefit from psychopharmacologic intervention and which can be treated with nonpharmacologic methods, alone.
Assess the efficacy and safety of pharmacologic options available to treat aggression and agitation in patients with neuropsychiatric and neurodegenerative disorders.
J. Michael Ryan, MD, is a consultant for Bristol-Myers Squibb Company. He receives research support from Janssen Research Foundation and Mitsubishi Pharma Corporation. He is also on the speakers’ bureau for Abbott Laboratories; AstraZeneca; Bristol-Myers Squibb Company; Eisai Inc.; Forest Pharmaceuticals, Inc.; and Janssen Pharmaceutica Inc. He intends to discuss unapproved/investigative uses of pharmacologic products.
Lori Daiello, PharmD, is a consultant for Abbott Laboratories; AstraZeneca; Eli Lilly and Company; Forest Pharmaceuticals, Inc.; and Pfizer, Inc. She is also on the speakers’ bureau for Abbott Laboratories; AstraZeneca; Bristol-Myers Squibb Company; Eli Lilly and Company; Forest Pharmaceuticals, Inc.; and Pfizer, Inc. She intends to discuss unapproved/investigative uses of pharmacologic products.
Joseph P. Moore, MS, has received honoraria from Eisai Inc. and Pfizer, Inc. Pharmaceuticals. He intends to discuss unapproved/investigative uses of pharmacologic products.
CPE: This program (UPN# 203-999-04-091-H01) was developed by the American Society of Consultant Pharmacists (ASCP) and is approved for 1.0 Contact Hour (0.1 CEU). ASCP is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education.
This program was originally presented as a live audioconference series beginning in July 26, 2004. If you participated in the live audioconference (UPN# 203-999-04-091-C01), or in the subsequent audio-CD/workbook version, you are not eligible to receive continuing education credit through this online program.
CME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc. and Medical Communications Media, Inc. AKH Inc. is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc. designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
Nursing CE: This program has been approved for 1.2 hours of continuing nursing education by AKH Inc. AKH Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Nurse Practitioner CE: This program has been approved for 1.2 hours of continuing education for nurse practitioners by AKH Inc. AKH Inc. is approved as a provider of nursing and nurse practitioner continuing education by the American Academy of Nurse Practitioners. #03803
AAPA accepts Category I CME credit for the PRA from organizations accredited by the ACCME. All programs on cmecorner.com that carry ACCME Category I CME credit are acceptable toward the PA Category I (Preapproved) CME requirement.
PAs requesting credit should check the "Physician" box on the post-test.
All types of Credit: Participants must successfully complete the post-test (70% or higher) and submit an evaluation to receive credit.
The release date of this activity is July 26, 2004. Credit expiration date is January 31, 2006. Commercial Support Statements
Supported by an educational grant from AstraZeneca.
Click on the "Start program" icon.
The next screen will permit you to check for or download Flash, required to run this program. You will also find buttons that will permit you to start the program presentation, access other program elements, and take the post-test.
Clicking on "start the program" on this screen will begin the program presentation, which will take approximately 1 hour to complete.
You must be registered with cmecorner.com in order to complete the post-test. When you click on the post-test button you will be brought to a screen that will confirm your registration status and provide an opportunity to register if you haven't done so previously.
Instructions for completing and submitting the post-test are provided on the post-test screen. A minimum score of 70% on the post-test is required for a Statement of Credit.
None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, AKH Inc., the American Society of Consultant Pharmacists or AstraZeneca. Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients’ conditions and of possible contraindications or risks, and without a review of any applicable manufacturer’s product information and comparison with the recommendations of other authorities.